Course Catalog


  • Dr. Orn Almarsson

    works for Alkermes, USA

  • Magid Abou-Gharbia, Ph.D., FRSC

    is currently the Associate Dean for Research, Professor of Medicinal Chemistry and Director of the Moulder Center for Drug Discovery Research (MCDDR) at the School of Pharmacy, Temple University, Philadelphia, PA.

  • Terry Acree

    is a professor at Cornell University.

  • Sreedhara Alavattam

    is currently a senior group leader in the Late Stage Pharmaceutical Development group at Genentech, South San Francisco, CA.

  • Harry Allcock

    is an Evan Pugh Distinguished Professor of Chemistry at the Pennsylvania State University

  • Dennis Anderson

    retired from Akzo Nobel Surfactants America following a 40+-year career as an industrial analytical chemist and taught HPLC Basics OnDemand.

  • Dr. Kelly Anderson

    is currently a Senior Scientist in Corporate R&D, Modeling and Simulation, at The Procter & Gamble Company in Cincinnati, Ohio.

  • Ed Askew

    is currently an Assistant professor in the Chemistry Department at Ashford University and the Technical Director of LaBServe, a laboratory training company.

  • Athula Attygalle

    is a faculty member in the Department of Chemistry, Chemical Biology and Biomedical Engineering at Stevens Institute of Technology, Hoboken, New Jersey. He joined Stevens in 2001, after serving ten years as the Director of the mass spectrometry facility of Cornell University.

  • Dr. Frank Axe

    is currently a faculty member at the University of the Pacific and San Joaquin Delta College and has held positions at Accelrys, Ontogen, and Johnson & Johnson.

  • Donald G. Baird

    is the Harry C. Wyatt Professor of Chemical Engineering at Virginia Tech, Blacksburg, Virginia.

  • Bhavani Balasubramanian

    has over 12 years of research experience in the area of biochemistry and molecular biology. Her most recent industry experience was as a manager of Clinical Efficacy at AVON Products Inc.

  • Lisa Balbes

    teaches Preparing Perfect Scientific Presentations.

  • Michael Balogh

    is a technology consultant and former consulting principal scientist and Director of Strategic Collaborations at Waters Corporation.

  • William Bentley

  • Brian A. Bidlingmeyer, Ph.D.

    is the Separations Business Manager for HPLC Columns at Agilent Technologies.

  • James Bond

    is a toxicological consultant to clients in the private and public sectors.

  • Sabra Botch-Jones

    Ms. Botch-Jones is a Forensic Toxicologist and a full-time faculty member of the Biomedical Forensic Sciences Program. She earned her Master of Science degrees in Drug Chemistry (2007) and Forensic Toxicology (2009) from the University of Florida.

  • Dr. J. Phillip Bowen

    is Professor of Pharmaceutical Sciences and Director of the Center for Drug Design in the Collage of Pharmacy and Health Sciences at Mercer University.

  • Kurt A. Brorson

    is a staff scientist in CDER?s Division of Monoclonal Antibodies, Office of Biotech Products.

  • Keith Cadwallader

    works for University of Illinois.

  • William Cain

    works for University of California San Diego.

  • Scott W. Case

    is Professor of Engineering Science and Mechanics, Virginia Tech, Blacksburg, Virginia.

  • Byeong S. Chang

    is a founder of Integrity Biosolution.

  • David Christ

    of SNC Partners is a consultant and service provider to the pharmaceutical industry and academia. Dr. Christ spent 17 years in the pharmaceutical industry in drug discovery and preclinical development in positions ranging from Director of Research Support in the Drug Metabolism and Pharmacokinetics departments of the Dupont Pharmaceutical Co. and Bristol Myers Squibb to Vice President of Preclinical Development at the Adolor Corporation. He has served on the Executive Committee of the Drug Metabolism Section of ASPET and is currently a member of the Editorial Board of Drug Metabolism and Disposition.

  • Marcus Cicerone

    is Biomaterials Group Leader in the Polymers Division at the National Institute of Standards and Technology and teaches as part of Formulation Development and Drug Delivery Systems.

  • Dr. Patrick Connelly

    works for Vertex Pharmaceuticals, USA

  • Roger R. Conrad, CSP, CCHO

    is currently a Hazardous Materials Specialist with the Lehigh County (PA) Special Operations Team and the Assistant Fire Chief of Good Will Fire Company #1 Trexlertown (PA). He retired after 37 years with Air Products and Chemicals, Allentown, Pennsylvania where he was a Senior Principal Safety Specialist for 26 years and a research chemist for 11 years.

  • Mary E. M. Cromwell

    is Associate Director of Protein Analytical Chemistry at Genentech, Inc.

  • Kathryn Deibler, Ph.D.

    is a consultant innovatively applying her research capabilities and creative interest for beverage companies.

  • Jeannine Delwiche

    works for Firmenich.

  • Stanley N. Deming

    is Professor Emeritus of Chemistry at the University of Houston, Houston, Texas.

  • Rosemary DeRose

    teaches our webcast demonstration sessions.

  • Milind S. Deshpande

    is Executive Vice President of Research & Chief Scientific Officer of Achillion Pharmaceuticals, Inc. and a co-chair of the Tactical Approaches to the Challenge of Drug Failure ACS ProSpectives Conference.

  • Bill Deutsch

    has spent thirty years in the groundwater industry as a research geochemist (13 years at Pacific Northwest National Laboratory) and an applied geochemist (17 years) with environmental consulting firms.

  • Li Di

    is Associate Research Fellow in Pharmacokinetics, Dynamics and Metabolism at Pfizer. She is involved with ADME property assessment, method development and consults with teams on property optimization.

  • David A. Dillard

    is Professor of Engineering Science and Mechanics, Virginia Tech., Blacksburg, Virginia.

  • John G. Dillard

    is Professor of Chemistry, Virginia Tech, Blacksburg, Virginia.

  • Dr. Ulf Dolling

    (B.S. Univ. of Hamburg, Ph.D. Rutgers) was Executive Director of Process Research prior to his retirement in 2005 and teaches Process Research in the Pharmaceutical Industry: The Design and Development of Practical Syntheses.

  • Michael W. Dong

    is a principal in MWD Consulting. He was formerly Senior Scientist at Genentech, Research Fellow at Purdue Pharma, and Staff Scientist at Perkin-Elmer. He holds a Ph.D. in Analytical Chemistry from City University of New York and has 100+ publications and 3 books.

  • Dr. Douglas Dudis

    has broad experience in computational chemistry, with special expertise in quantum methods applied to organic materials for electronic, nonlinear optical applications, as well as energy technologies such as fuel cells, batteries and photovoltaics.

  • Martin Echols

    Martin Echols received his Bachelor’s degree in Biology from the University of Denver in Colorado.

  • Kevin Edgar

    is a Professor in the Wood Science and Forest Products Department at Virginia Tech, Blacksburg, Virginia.

  • Ayman El-Kattan

    is Associate Research Fellow at the Pharmacokinetics, Dynamics, and Metabolism Department, Pfizer Inc. Groton Laboratories.

  • Alan R. Esker

    is an Assistant Professor of Chemistry, Virginia Tech., Blacksburg, Virginia .

  • Christine Fandozzi

    works for Merck.

  • Vittorio Farina

    of Johnson & Johnson is one of the Co-Chairs of the Process Chemistry in the Pharmaceutical Industry with Special Emphasis on Continuous Manufacturing ACS ProSpectives Conference.

  • Kathleen Farley

    is a Principal Scientist in the R&D division at Pfizer Inc with over 25 years of experience in the pharmaceutical industry.

  • Dr. Barry L. Farmer

    is Chief Scientist in the Materials and Manufacturing Directorate, Air Force Research Laboratory (AFRL), Wright-Patterson Air Force Base, Ohio.

  • Erik J. Fernandez

    is a professor of Chemical Engineering at the University of Virginia, where he has been on the faculty since 1991.

  • Stuart Firestein

    works for Columbia University.

  • Carolyn Fisher

    is the Global Science Network Manager at McCormick & Company.

  • Chip Frazier

    is the T.M. Brooks Professor of Wood Science and Forest Products and Director of the Wood-Based Composites Center.

  • Dr. Joel R. Fried

    is Professor and Chair, Chemical Engineering, University of Louisville. He is author of Polymer Science and Technology, 3rd edition, 2014, Prentice Hall.

  • Lenart Girandon

    is CEO of CELL/TRY ltd.

  • Dr. David E. Gootnick

    is Managing Partner and Director of DAVID GOOTNICK ASSOCIATES, a New York-based management consulting firm, specializing in leadership development of scientists and engineers within technical organizations.

  • Dr. Ed Grabowski

    (B.S. MIT, Ph. D. Univ. of Rochester) was Vice President of Chemistry in Process Research at his retirement and teaches Process Research in the Pharmaceutical Industry: The Design and Development of Practical Syntheses.

  • Dr. Catherine Grgicak

    Dr. Grgicak received her doctorate in Chemistry from the University of Ottawa and is an Assistant Professor in the Biomedical Forensic Sciences Program at Boston University School of Medicine.

  • Richard G. Griskey

    is Institute Professor Emeritus of Chemistry and Chemical Engineering, Stevens Institute of Technology, Hoboken, New Jersey.

  • Robert B. Grossman

    has been a professor in the Department of Chemistry at the University of Kentucky since 1994. He is the author of The Art of Writing Reasonable Organic Reaction Mechanisms.

  • Ingolf Gruen

    is Associate Professor and program chair of food science at the University of Missouri, where he has been teaching, among other courses, food chemistry and food analysis since 1996.

  • Dr. Osman Gruner

    is a Principal with Turquoise Consulting, providing consulting, training, and contract research services in the pharmaceutical and biotechnology industry.

  • Fred Guengerich

    is the Harry Pearson Broquist Professor of Biochemistry, Vanderbilt University School of Medicine.

  • Lindy Harrison

    is Associate Professor of Organic Chemistry (retired) at York College of Pennsylvania where she taught organic chemistry and the capstone Physical Sciences seminar that included technical writing. Dr. Harrison teaches each of the following ACS Short Courses in-person and as webcasts: Essentials of Organic Chemistry, Effective Technical Writing, and Effective Technical Writing (English as a Second Language Version).

  • Greg Haugstad

    is technical staff member and director of the Characterization Facility (CharFac), a set of core research labs in the College of Science and Engineering at the University of Minnesota.

  • Paul Helquist

    is Professor and Associate Chair of Chemistry and Biochemistry at Notre Dame; Director of Project Development Team for translational therapeutics research at Notre Dame and other universities in Indiana.

  • Dr. Carl E. Heltzel

    was formerly the Monroe Moosnick Professor of Chemistry at Transylvania University and teaches the webcast course Essentials of Chemistry.

  • Susan Hershenson

    (Course Director) is Vice President, Vice President, Pharmaceutical and Device Development, Genentech and teaches as part of Formulation Development and Drug Delivery Systems.

  • Dr. Magali Hickey

    works for Alkermes, USA

  • Thomas Hofmann

    works for Technical University of Munich.

  • Griff Humphreys

    works for the Department of Biotransformation, Bristol-Myers Squibb.

  • Dr. Mick Hurrey

    Host Division Conference Organizer

  • Kim Huynh-Ba

    has almost 28 years of experience in GMPs, analytical development and stability sciences in Pharmaceutical Industry.

  • Kjell Johnson

    has worked as a statistician in the pharmaceutical industry for the past 12 years supporting a variety of drug discovery areas with a focus on computer aided drug discovery and pharmacokinetics, dynamics and metabolism.

  • Peter Karp

  • Leonard Katz

    is the Research Director of the Synthetic Biology Engineering Research Center (SynBERC) headquartered at the University of California, Berkeley.

  • Terry Kenakin

    has spent 32 years in industrial drug discovery, has won numerous awards for pharmacological research (Gaddum Memorial Award: 2014, Ariens Award: 2011, Poulsson Medal: 2008, IUPHAR Analytical Pharmacology Award: 2006), authored over 250 peer reviewed papers and reviews and written 10 books on Pharmacology.He also is Editor-in-Chief of Journal of Receptors and Signal Transduction and Co-Editor-in-Chief of Current Opinion in Pharmacology. He currently is Professor of Pharmacology at the University of North Carolina School of Medicine, Chapel Hill NC.

  • Edward H. Kerns

    has 34 years in drug discovery and development focused on ADMET properties and pharmacokinetics. He is co-author of the book Drug-Like Properties: Concepts, Structure Design and Methods, and has written and lectured widely.

  • Matthew Klee

    Matthew S. Klee, Ph.D. is a recognized authority in the area of GC analysis and instrumentation. For 23 years at HP/Agilent he has been directly involved in the development and marketing of market-leading GC and GC/MSD instrumentation

  • Miomir Knezevic

    is a CEO of biopharmaceutical biotech company Educell Ltd.

  • Dr. John Knight

    Scientific Director at Scientific Update

  • Dr. Meier zu Kocker

    is the Director General of the Agency Competence Cluster Germany, Managing Director at the Institute for Innovation and Technology, iit Berlin, Head of the Department for International Technology Transfer within VDI/VDE-IT, and Deputy General Manager at VDI/VDE-IT.

  • Christopher E. Kohler, CCHO, LPG

    is the Laboratory Safety Manager for Indiana University, Bloomington, Indiana. Mr. Kohler has 15 years of experience managing the laboratory chemical safety program for over 1000 research and teaching labs, and provides chemical safety training for over 500 scientists a year.

  • Dr. Claire Komives

    is presently an Associate Professor in the Chemical and Materials Engineering Department at San Jose State University (SJSU).

  • Andrew A. Kosky

    is a Senior Group Leader in the Early Stage Pharmaceutical Development department at Genentech.

  • Richard Kramer

    is President of Applied Chemometrics, Inc. and consults to instrumentation manufacturers and users.

  • Andrej Krzan

    is a senior scientific associate at the National Institute of Chemistry, Laboratory for Polymer chemistry and Technology, Ljubljana, Slovenia.

  • Max Kuhn

    is a Director at Pfizer Global R&D providing support for early drug discovery, target discovery, computational biology and chemistry.

  • Kristen Kulinowski

    is a PhD Chemist and director of International Council on Nanotechnology as well as executive director of NSF Center for Biological and Environmental Nanotechnology.

  • Dr. Philip Leber

    has 25+ years experience in toxicological and ecological assessments of chemicals in research, industrial & academic organizations. Dr. Leber teaches Ecological Impact of Chemicals (on demand) and the webcast course Toxicology For Chemists.

  • Mike Lee

    is a biotechnology entrepreneur and Founder and President of Milestone Development Services. He actively participates in the development of new technologies and their integration into industrial settings. Dr. Lee has more than 25 years of pharmaceutical industry experience. He has pioneered the application of LC/MS for research dealing with biomolecules, optimization of ADME and physicochemical properties, natural products, drug metabolites, impurities, and degradants.

  • Jane V. Leland

    is currently a Research Principal with Kraft Foods.

  • Abraham M. Lenhoff, Ph.D.

    is the Gore Professor of Chemical Engineering at the University of Delaware, where he has been on the faculty since 1984.

  • Bruce Lippy

    is a certified industrial hygienist, a certified safety professional and holds a Ph.D. in policy from the University of Maryland.

  • Timothy E. Long

    has been a faculty member in the Department of Chemistry since 1999 and serves as the Director of Macromolecules and Interfaces Institute (MII) at Virginia Tech. He spent nearly a decade as a research scientist at Eastman Kodak Company before returning to Virginia Tech as a Professor in the Department of Chemistry.

  • Dr. Claude A. Lucchesi

    is a recognized leader in analytical support laboratory management, with 14
    years of experience in industry and 25 years experience in a university environment.

  • Dr. Terry Lybrand, Ph.D.

    is a Professor of Chemistry and Pharmacology at Vanderbilt University.

  • Dr. Alan M. Lyons

    is a Professor of Chemistry at the City University of New York. He is also co-founder and CTO of ARL Designs LLC, a small business that develops high performance, low-cost superhydrophobic surfaces. Previously, he was a Distinguished Member of Technical Staff at Bell Laboratories.

  • Edward Malawer

    is currently President of Malawer & Associates Consulting, LLC and was previously (2007) Vice President in charge of Analytical R&D, Quality Assurance, Project Stewardship and the Technical Library at International Specialty Products. He teaches Introduction to Process Analytical Technology both in-person and as a webcast course.

  • Dr. Claude Mallet

    Dr. Mallet received his Ph.D. in analytical chemistry from the University of Montreal, Montreal, Canada (1997). His thesis was entitled “Time-Coupled-timed-Resolved Chromatography or TCRC”.

  • James E. Mark

    is Distinguished Research Professor of Chemistry at the University of Cincinnati, Cincinnati, Ohio and teaches Polymer Chemistry.

  • Edith Mathiowitz

    is Professor of Medical Services and Bioengineering, Brown University, Providence, Rhode Island and teaches as part of Formulation Development and Drug Delivery Systems.

  • Robert McGorrin

    works for Oregon State University.

  • James E. McGrath

    is University Distinguished Professor of Chemistry and Director, NSF Science and Technology Center on High Performance Polymeric Adhesives and Composites, Virginia Tech., Blacksburg, Virginias.

  • Harold McNair

    is Professor Emeritus of Chemistry, Virginia Tech, Blacksburg, Virginia.

  • Nicholas A. Meanwell

    is Executive Director of Discovery Chemistry at Bristol-Myers Squibb Research and Development and a co-chair of the Tactical Approaches to the Challenge of Drug Failure ACS ProSpectives Conference.

  • George Miesegaes

    George Miesegaes graduated in 2008 from Baylor College of Medicines Graduate
    School of Biomedical Sciences (Houston, TX) with a Ph.D. in Cell and Molecular Biology.
    His initial work at FDA involved the generation and analysis of a viral clearance database
    from monoclonal antibody regulatory submissions. This work has provided useful
    information pertaining to the robustness of viral clearance, and has led to a variety of
    research projects of which he is currently involved. George is the newest member of the OBP/CDER Bioprocessing Lab, headed by Dr. Kurt Brorson. He currently spends 80% of his time performing regulatory research, and the remainder of his time as a CMC reviewer for CDER/DMA. He has served on the Organizing and Editorial committees for the 2009 Viral Clearance Symposium, and has written various articles on the subject of viral clearance since his arrival to FDA.

  • Bob Migliorini

    is an in-house patent attorney and teaches Patent Law Fundamentals.

  • Kaushik Mitra

    works for the Department of Drug Metabolism, Merck Research Laboratories.

  • Shahriar Mobashery

    is a Professor of Chemistry and holds the Navari Family Chair in Life Sciences at Notre Dame University.

  • Shib Mookherjea

    is a globally acclaimed speaker and consultant and has extensive experience in R&D, quality assurance, and quality management.

  • Robert B. Moore

    is a Professor of Chemistry and the Director of the Macromolecular Science and Engineering Graduate Degree Program at Virginia Tech., Blacksburg, Virginia.

  • Stephen L. Morgan

    is a Professor in the Department of Chemistry & Biochemistry at the University of South Carolina (Columbia, SC). He has has coauthored 120 papers and four books, including Experimental Design: A Chemometric Approach (1993) and Sequential Simplex Optimization for Quality & Productivity in Research, Development, and Manufacturing (1991).

  • Ian Morrison

    is President of Owen Research, a Lecturer at Harvard University, Adjunct Prof. at Georgetown University, and Director of Corporation Relations for the Soft Matter Institute at Georgetown University. He has published two textbooks and taught ACS short courses for more than 25 years.

  • Mo Movassaghi

    is from MIT and is one of the Co-Chairs of the Process Chemistry in the Pharmaceutical Industry with Special Emphasis on Continuous Manufacturing ACS ProSpectives Conference.

  • Barbara Mowery

    Barbara Mowery, Chemistry Lab Coordinator at York College of PA, and Professor Emeritus, Thomas Nelson Community College (Hampton VA), brings a variety of experience to the Effective Technical Writing course. Teaching at different levels, managing several types of labs, and writing and reviewing educational materials has helped her become a skilled coach in helping others to write clearly and concisely.

  • Michael Moxness, Ph.D., DABCC

    , is a Principal Scientist in Clinical Immunology at Amgen.

  • Martin Mulvihill

    is a PhD chemist and is the Executive Director for the Berkeley Center for Green Chemistry (BCGC) and postdoctoral researcher in both Public Health and Environmental Engineering.

  • Nagu Nagarajan

    Professor “Nagu” Nagarajan received his Ph.D. from the State University of New York at Buffalo in chemical engineering in 1979. He began his career at The Pennsylvania State University in 1979 where he established a theoretical and experimental research programs in colloid, polymer and surfactant science. He retired from Penn State in 2005 as Emeritus Professor of Chemical Engineering, to start a research program at the U.S. Army Natick Soldier Research, Development & Engineering Center. He was elected a Fellow of the American Chemical Society in 2012.

  • William Neil

    He has been employed in the pharmaceutical industry since 1992, where he has written several applications in C#, Iron Python, Visual Basic and VBA to automate the Drug Discovery process, particularly in the area of instrument integration.

  • Ann Newman

    is currently a pharmaceutical consultant at Seventh Street Development Group with over 20 years of large pharma and contract research experience. She teaches Polymorphism in Organic/Pharmaceutical Systems.

  • Dr. Drazen Ostovic

    works for Amgen, USA

  • Dr. Sadettin Ozturk

    is the head of Bioprocess Technology at Centocor/ Johnson & Johnson. His group is responsible for process and technology development, process scale-up and optimization for cell culture based pharmaceuticals.

  • Richard Partch

    is a Senior University Professor in the Center for Advanced Materials Processing at Clarkson University.

  • Robert Peoples

    is a PhD chemist and director of the ACS Green Chemistry Institute. In this capacity, he drives the implementation of the principles of green chemistry across the global chemical enterprise.

  • Dr. Masha Petrova

    is a founder and CEO of MVP Consulting Solutions – a company focused on bridging the gap between technical experts, marketing and sales and customers.

  • Lee N. Polite

    is the President and Laboratory Director, Axion Analytical Laboratories.

  • Todd M. Przybycien, Ph.D.

    , is Professor of Chemical Engineering and Biomedical Engineering at Carnegie Mellon University and teaches Chemical Engineering for Chemists.

  • Dr. Marquita M. Qualls

    is the Founder and Senior Managing Partner of Entropia Consulting, a boutique management consulting firm that focuses on helping individuals become more effective leaders, and helping organizations cultivate and align business strategies to achieve maximum productivity.

  • Dr. Ragu Ramanathan

    is an Associate Director in the Department of Biotransformation at Bristol-Myers Squibb, Princeton, NJ. With over 20 years of experience in mass spectrometry, Dr. Ramanathan?s primary focus of research involves application of LC-MS for pharmaceutical drug discovery and development.

  • Anurag S. Rathore

    is a consultant of Biotech CMC Issues. He is also a faculty at the Department of Chemical Engineering, Indian Institute of Technology, Delhi, India.

  • Nitin Rathore

    is a Senior Scientist in Drug Product and Device Development at Amgen.

  • Judy S. Riffle

    Professor of Chemistry, Virginia Tech, studies the synthesis of functionalized homopolymers and block copolymers and their activity in metal complexation and particle formation and in understanding structure-property relationships in thermoset copolymer networks.

  • Sara Risch

    is the principal in Science by Design, a consulting firm she founded in 1993.

  • Maren Roman

    is an Assistant Professor in the Wood Science and Forest Products Department at Virginia Tech, Blacksburg, Virginia.

  • Scott Rychnovsky

    is Professor of Chemistry, University of California, Irvine, California and teaches Asymmetric Synthesis.

  • Dr Mahmood Sabahi

    Research and Development executive with more than 22 years of experience in industrial R & D and 10 years of experience in teaching and research in academia.

  • Gavin Sacks

    works for Cornell University.

  • Gideon Samid

    is a chemical and a nuclear engineer with broad experience (NASA, Exxon, DoD) specializing in the bench-to-production process, estimating the effort to achieve an R&D objective, and mathematical engineering applications. Dr. Samid earned his degrees at the Technion — Israel Institute of Technology, holds some patents, and published a critically acclaimed book: “Computer Organized Cost Engineering.”

  • Rakhi B. Shah

    is currently employed with U.S. Food and Drug Administration as a Pharmacologist.

  • Ze've Shaked

    is currently the President and CEO of Evestra Inc. He was President and CEO of Spherics, Inc. Prior to that, he served as President of ILEX Products, Inc. and COO of ILEX Oncology, Inc. Dr. Shaked has held a number of senior R&D and corporate management positions at ImmuLogic Pharmaceutical Corporation, Triton Biosciences, Inc., and Cetus/Chiron Corporation. He has extensive experience in formulation development and delivery of therapeutics, including peptide-based drugs. He obtained his Ph.D. in bio-organic chemistry from MIT.

  • Vikas K. Sharma

    is currently a Group Leader and Sr. Scientist in the Early Stage Pharmaceutical Development department at Genentech, South San Francisco, CA.

  • Brian C. Smith, Ph.D.

    is founder and Principal of Spectros Associates in Shrewsbury, Massachusetts.

  • Pam Spencer

    is an Associate Director of TERC Product Sustainability Consulting. She also serves as a toxicology consultant to Dow businesses, providing guidance on the health and safety of new and existing products.

  • Ganesh Sriram

  • Ranjan Srivastava

  • Dr. G. Patrick Stahly

    was an R&D Advisor at Albemarle Corp. and COO of SSCI, a contract research company specializing in solid-state chemistry. He is the founder of Chemfocus LLC and Triclinic Labs.

  • Ross Stein

    has worked at Merck, where he headed the Enzymology Department, ProScript (acquired by Millennium in 1999) as vice president of biochemistry, Harvard Medical School to establish and head the Laboratory for Drug Discovery in Neurodegeneration, and as vice president of drug discovery at Sirtris Pharmaceuticals. In fall of 2011, Dr. Stein accepted the position of Deputy Director of the Institute for Advancing Medical Innovation of the University of Kansas Medical Center. He teaches Kinetics of Enzyme Action – Basic Principles for Drug Hunters.

  • Douglass F. Taber

    is currently Professor of Chemistry at the University of Delaware and has published more than 150 research papers on organic synthesis and organometallic chemistry. Dr. Taber teaches NMR Spectral Interpretation and Organic Spectroscopy: A Problem-Based Learning Approach and Recent Developments in Organic Synthesis.

  • Andrew Taylor

    works for University of Nottingham.

  • Jörg Thommes, Ph.D.

    is currently employed at Biogen Idec where he is the Vice President of Biopharmaceuticals Development responsible for biologics manufacturing process development including cell culture, purification, formulation and drug product.

  • Jeffrey Toney

    is Dean of the College of Natural, Applied and Health Sciences at Kean University and teaches Essentials of Biochemistry for Drug Hunters.

  • Dr. Alexander Tropsha

    is K.H. Lee Distinguished Professor and Associate Dean for Research at the UNC Eshelman School of Pharmacy, UNC-Chapel Hill and teaches Computer-Assisted Drug Design.

  • Dr. Barry M Trost

    , Course Director, is Tamaki Professor of Humanities and Sciences at Stanford University, Palo Alto, California.

  • S. Richard Turner

    is the Director of the Macromolecules and Interfaces Institute at Virginia Tech, Blacksburg, Virginia.

  • Marek W. Urban

    is J.E. Sirrine Foundation Endowed Chair and Professor at Clemson University, Department of Materials Science and Engineering. He directed the NSF Materials Research Science and Engineering Center (MRSEC) on Stimuli-Responsive Polymeric Films and Coatings as well as the Industry/University Cooperative Research Center (I/U CRC) in Coatings. He has years of research and teaching experience in polymers and coatings, including faculty positions at North Dakota State and University of Southern Mississippi.

  • Elizabeth B. Vadas, PhD

    has over 30 years of experience in pharmaceutical research.

  • Ganesh Vedantham, Ph.D.

    is the functional Director of Purification Process Development group at Amgen.

  • Raghavan V. Venkat, Ph. D.

    is currently employed at MedImmune where he is Director, R&D and leads process cell culture and fermentation teams responsible for development of cell lines and cell culture/fermentation processes for biologics at MedImmune.

  • Hugo O. Villar, Ph.D.

    , MBA is President of Altoris, Inc. a San Diego based specializing in chemical information management and providing consulting in computer assisted drug design.

  • Greg Walker

    is a Senior Principal Scientist at Pfizer Inc with 20+ years of experience in the pharmaceutical industry.

  • Fran Waller

    is a recently retired Senior Research Associate from Air Products and Chemicals, Inc. with more than 34 years of experience in industry and teaching. He holds 45 U.S. and 23 foreign patents. In addition, Dr. Waller has published 70 scientific articles.

  • Dr. Perry G. Wang

    is a chemist in the Office of Regulatory Science, US Food and Drug
    Administration (US FDA). His interests include analytical method development and validation for drugs and constituents of foods and cosmetic products using advanced instrumentation. His expertise focuses on high throughput drug analysis by LC/MS/MS for the pharmaceutical industry.

  • Thomas C. Ward

    Adhesives and Sealants Council Chaired Professor of Chemistry, Virginia Tech, focuses on polymer characterization, viscoelasticity, mechanical properties, and molecular interpretations of behavior in his research and teaching. His current studies include adhesion of coatings and thin films.

  • Will Watson

    He is active in the consultancy side of the business and sits on the Scientific Advisory Boards of various companies.

  • Robert Weinberger

    is the President of CE Technologies, Inc.

  • Barry M. Weinstein

    is the President of Barry M. Weinstein & Associates, a consulting firm providing project management, product development, process engineering, and statistical quality control support for the food and personal care product industries.

  • Garth L. Wilkes

    is Emeritus University Distinguished Professor of Chemical Engineering, Virginia Tech., Blacksburg, Virginia and teaches as part of the lecture/laboratory courses Polymer Chemistry: Principles and Practice and Fundamentals of Polymers and Interfaces for Adhesives, Composites, and Sustainable Structures.

  • Dr. Richard Williams

    Dr. Richard Williams is the founder and President of Environmental Science & Green Chemistry Consulting, LLC

  • Bruce M. Winchell, J.D.

    is licensed to practice law in Ohio, Tennessee, U.S. Patent Office and Canadian Patent Office. He is a Certified Licensing Professional. He has significant experience in Intellectual Property law in large companies and DOE National Laboratories. He has been teaching this topic on a regular basis since 2007.

  • Keith Woerpel

    is Assistant Professor of Chemisty, University of California, Irvine, and teaches Asymmetric Synthesis.

  • Gerard D. Wright

    (Course Director) is the Director of the M.G. DeGroote Institute for Infectious Disease Research and Professor of Biochemistry and Biomedical Sciences at McMaster University, Hamilton, Ontario and teaches Antibiotics and Antibacterial Agents.

  • Dr. David Wylie

    Program Manager at the American Chemical Society – Green Chemistry Institute®

  • Dalia Yablon

    holds an A.B. in Chemistry from Harvard University and a Ph.D. in Physical Chemistry from Columbia University.

  • Jennifer Young

    is a PhD chemist and manager at ACS GCI, with focus on producing educational materials and workshops, managing awards and grants programs, and communicating through presentations.

  • Paul Zavitsanos

    is an application scientist and product specialist at Agilent Technologies and teaches Practical LC/MS.

  • Dr. Donglu Zhang

    is a Principal Scientist at Bristol-Myers Squibb in Princeton, NJ. Dr. Zhang has frequently taught short courses at ACS and EAS, is a co-editor of the book ?Drug metabolism in drug design and development?, a co-inventor of mass defect filtering technology, and has published >60 peer-reviewed articles.

  • Dr. Mingshe Zhu

    is a drug metabolism researcher at Bristol-Myers Squibb and teaches Introduction to Drug Metabolism.

  • Dr. Alexis Zrimec

    PhD biology, biophysics, is the Director of Technology Department and International Programmes at CE PoliMaT.

  • Dr. Maja Berden Zrimec

    currently deals with biopolymers and degradable polymers for sustainable development in Center of Excellence PoliMaT, bringing global biopolymer knowledge and experience into under-developed countries with a goal to find the solutions for local problems using Biopolymer Workshops, Talent Camps and Training Courses.